Man Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Buy
245,944
+34,654
+16% +$552K 0.01% 1336
2025
Q4
$3.43M Buy
211,290
+120,129
+132% +$1.96M 0.01% 1238
2025
Q3
$1.36M Sell
91,161
-3,457
-4% -$42.1K ﹤0.01% 1560
2025
Q2
$1.1M Sell
94,618
-43,984
-32% -$400K ﹤0.01% 1606
2025
Q1
$1.03M Sell
138,602
-150,087
-52% -$1.15M ﹤0.01% 1574
2024
Q4
$1.73M Buy
288,689
+128,317
+80% +$707K 0.01% 1356
2024
Q3
$821K Sell
160,372
-24,079
-13% -$105K ﹤0.01% 1544
2024
Q2
$668K Buy
184,451
+6,444
+4% +$20.5K ﹤0.01% 1602
2024
Q1
$571K Buy
178,007
+6,938
+4% +$26.8K ﹤0.01% 1738
2023
Q4
$838K Buy
+171,069
New +$781K ﹤0.01% 1509
2023
Q3
Sell
-122,508
Closed -$810K 1437
2023
Q2
$822K Buy
+122,508
New +$911K ﹤0.01% 1450
2023
Q1
Sell
-93,764
Closed -$827K 1354
2022
Q4
$716K Sell
93,764
-59,287
-39% -$461K ﹤0.01% 1417
2022
Q3
$1.09M Buy
+153,051
New +$1.44M 0.01% 1256
2022
Q2
Sell
-89,698
Closed -$789K 1253
2022
Q1
$1.25M Buy
89,698
+8,102
+10% +$127K ﹤0.01% 1321
2021
Q4
$2.29M Sell
81,596
-26,981
-25% -$827K 0.01% 1142
2021
Q3
$3.69M Sell
108,577
-364
-0.3% -$13.2K 0.01% 967
2021
Q2
$4.45M Sell
108,941
-35,794
-25% -$1.39M 0.02% 936
2021
Q1
$5.83M Buy
144,735
+3,029
+2% +$164K 0.03% 619
2020
Q4
$8.38M Sell
141,706
-3,398
-2% -$175K 0.04% 513
2020
Q3
$7.06M Sell
145,104
-11,527
-7% -$484K 0.03% 634
2020
Q2
$7.58M Buy
156,631
+134,288
+601% +$4.9M 0.04% 475
2020
Q1
$621K Sell
22,343
-408,466
-95% -$11.4M ﹤0.01% 1229
2019
Q4
$12.9M Buy
430,809
+369,397
+602% +$10.6M 0.04% 553
2019
Q3
$1.9M Buy
+61,412
New +$2.51M 0.01% 1261

Other funds holding ADPT